Cited 1 time in
Importance of total radiation dose and overall treatment time in T1 early glottic cancer
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Song, J. H. | - |
| dc.contributor.author | Jeong, B. K. | - |
| dc.contributor.author | Lee, Y. H. | - |
| dc.contributor.author | Choi, H. S. | - |
| dc.contributor.author | Jeong, H. | - |
| dc.contributor.author | Jang, H. S. | - |
| dc.contributor.author | Choi, B. O. | - |
| dc.contributor.author | Kang, K. M. | - |
| dc.date.accessioned | 2022-12-26T17:18:35Z | - |
| dc.date.available | 2022-12-26T17:18:35Z | - |
| dc.date.issued | 2018-01 | - |
| dc.identifier.issn | 2322-3243 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/12054 | - |
| dc.description.abstract | Background: In this study, we retrospectively reviewed the treatment outcome of 63 patients with T1 early glottic cancer treated with RT alone to determine the treatment outcome and the prognostic factors affecting local control. Materials and Methods: All patients were treated by 6 MV photons with conventional bilateral fields up to a median dose of 66 Gy in 33 fractions. Results: The 5-year local control rate and overall survival were 77.7% and 93.1%, respectively. The total radiation dose with a cut-off value of 66 Gy was a significant prognostic factor for local control. The 5-year local control rate was 54.5% in patients treated with less than 66 Gy compared to 85.7% in patients treated with 66 Gy or higher dose (p = 0.014). In subgroup analysis, in patients who received 66 Gy or higher doses, all recurrences developed in whose overall treatment time was 49 days or longer, although the statistical significance was marginal (p = 0.066). Conclusion: This study showed that a total dose of 66 Gy or higher is required for the treatment of T1 glotic cancer, and delivering the total dose within 49 days seems important for local control. | - |
| dc.format.extent | 8 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | IJRR-IRANIAN JOURNAL RADIATION RES | - |
| dc.title | Importance of total radiation dose and overall treatment time in T1 early glottic cancer | - |
| dc.type | Article | - |
| dc.publisher.location | 이란 | - |
| dc.identifier.doi | 10.18869/acadpub.ijrr.16.1.17 | - |
| dc.identifier.scopusid | 2-s2.0-85043228844 | - |
| dc.identifier.wosid | 000427559900003 | - |
| dc.identifier.bibliographicCitation | INTERNATIONAL JOURNAL OF RADIATION RESEARCH, v.16, no.1, pp 17 - 24 | - |
| dc.citation.title | INTERNATIONAL JOURNAL OF RADIATION RESEARCH | - |
| dc.citation.volume | 16 | - |
| dc.citation.number | 1 | - |
| dc.citation.startPage | 17 | - |
| dc.citation.endPage | 24 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Radiology, Nuclear Medicine & Medical Imaging | - |
| dc.relation.journalWebOfScienceCategory | Radiology, Nuclear Medicine & Medical Imaging | - |
| dc.subject.keywordPlus | SQUAMOUS-CELL CARCINOMA | - |
| dc.subject.keywordPlus | INTENSITY-MODULATED RADIOTHERAPY | - |
| dc.subject.keywordPlus | LOCAL-CONTROL | - |
| dc.subject.keywordPlus | PROGNOSTIC-FACTORS | - |
| dc.subject.keywordPlus | FRACTION SIZE | - |
| dc.subject.keywordPlus | MULTIVARIATE-ANALYSIS | - |
| dc.subject.keywordPlus | VOCAL CORD | - |
| dc.subject.keywordPlus | THERAPY | - |
| dc.subject.keywordPlus | LARYNX | - |
| dc.subject.keywordPlus | COMPLICATIONS | - |
| dc.subject.keywordAuthor | Early glottic cancer | - |
| dc.subject.keywordAuthor | radiation therapy | - |
| dc.subject.keywordAuthor | radiation dose | - |
| dc.subject.keywordAuthor | treatment time | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
